In conclusion, our findings indicate that elevated MRPL3 expression correlates with poor prognosis in PC and immunosuppressive TME, marked by increased Th2 cell infiltration and G2/M checkpoint dysregulation. Here, MRPL3 is linked to pachyonychia congenita.